KAS
CTIC

Kestra Advisory Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Kestra Advisory Services’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,850
Closed -$179K – 2352
2022
Q4 		$179K Buy
29,850
+4,650
+18% +$27.9K ﹤0.01% 2049
2022
Q3 		$147K Buy
25,200
+7,695
+44% +$44.9K ﹤0.01% 1925
2022
Q2 		$105K Buy
+17,505
New +$105K ﹤0.01% 1986